Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection

Por Thursz, Mark
Publicado em 2007

Screening and treatment of hepatitis B virus to prevent liver cancer in Africa

Por Thursz, Mark R
Publicado no Hepat Oncol (2015)

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Por Tanwar, Sudeep, Thursz, Mark
Publicado em 2010

Breaking Down Barriers to Care in Hepatitis C Virus Infection

Por Thursz, Mark, Lacombe, Karine
Publicado no J Infect Dis (2016)

Intensive Enteral Nutrition in Alcoholic Hepatitis: More Food for Thought

Por PURI, PUNEET, THURSZ, MARK
Publicado no Gastroenterology (2016)

Treatment of Severe Alcoholic Hepatitis

Por Thursz, Mark, Morgan, Timothy R.
Publicado no Gastroenterology (2016)

Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges

Por Lemoine, Maud, Nayagam, Shevanthi, Thursz, Mark
Publicado em 2013

Design, method and application of stopping rules in a phase III 2x2 factorial randomised controlled trial

Por Bowers, Megan, Stanton, Louise, Thursz, Mark
Publicado no Trials (2015)

The future of therapy for alcoholic hepatitis – Beyond corticosteroids

Por Vergis, Nikhil, Atkinson, Stephen R., Thursz, Mark R.
Publicado no J Hepatol (2019)

Detection of allele specific differences in IFNL3 (IL28B) mRNA expression

Por Knapp, Susanne, Meghjee, Naeem, Cassidy, Sorcha, Jamil, Khaleel, Thursz, Mark
Publicado no BMC Med Genet (2014)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example

Por Kumar, Abhinav, Gangadharan, Bevin, Cobbold, Jeremy, Thursz, Mark, Zitzmann, Nicole
Publicado no Sci Rep (2017)

Functional imaging of hepatocellular carcinoma

Por Hoogenboom, Tim CH, Thursz, Mark, Aboagye, Eric O, Sharma, Rohini
Publicado no Hepat Oncol (2016)

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

Por Heffernan, Alastair, Cooke, Graham S, Nayagam, Shevanthi, Thursz, Mark, Hallett, Timothy B
Publicado no Lancet (2019)

Presence of hepcidin-25 in biological fluids: Bile, ascitic and pleural fluids

Por Arnold, Jayantha, Sangwaiya, Arvind, Manglam, Vijay, Geoghegan, Frank, Thursz, Mark, Busbridge, Mark
Publicado em 2010

Next-Generation Sequencing Sheds Light on the Natural History of Hepatitis C Infection in Patients Who Fail Treatment

Por Abdelrahman, Tamer, Hughes, Joseph, Main, Janice, McLauchlan, John, Thursz, Mark, Thomson, Emma
Publicado no Hepatology (2015)

Reply

Por Abdelrahman, Tamer, Hughes, Joseph, Main, Janice, McLauchlan, John, Thursz, Mark, Thomson, Emma
Publicado no Hepatology (2015)

Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes

Por Arnold, Jayantha, Sangwaiya, Arvind, Manglam, Vijay, Thursz, Mark, Beaumont, Caroline, Kannengiesser, Caroline, Busbridge, Mark
Publicado em 2010

Hepatitis B: A Current Global Health Dilemma

Por Howell, Jessica, G Ladep, Nimzing, Lemoine, Maud, R Thursz, Mark, Taylor-Robinson, Simon D
Publicado no Euroasian J Hepatogastroenterol (2014)

1171. Impact on Mortality, Length of Stay, and Antibiotic Use in Allogenic and Autologous Stem Cell Transplant Patients Colonized With Carbapenemase-Producing Enterobacteriaceae

Por Ghani, Rohma, Mookerjee, Siddharth, Mullish, Benjamin, Thursz, Mark, Marchesi, Julian, Pavlu, Jiri, Davies, Frances
Publicado no Open Forum Infect Dis (2018)

Correspondence: Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant

Por Mullish, Benjamin H, McDonald, Julie A K, Thursz, Mark R, Marchesi, Julian R
Publicado no Hepatology (2018)